Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors.

Molecular nutrition & food research - 1 Jan 2017

Reverri Elizabeth J, Slupsky Carolyn M, Mishchuk Darya O, Steinberg Francene M

Abstract excerpt

SCOPE: The soy isoflavone, daidzein, is metabolized by gut microbiota to O-desmethylangolensin (ODMA) and/or equol. Producing equol is postulated as a contributing factor for the beneficial effects of soy. METHODS AND RESULTS: This randomized, controlled, cross-over design used an untargeted metabolomic approach to assess the metabolic profile of different daidzein metabolizers. Adults (n = 17) with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Food
Share to Glycine max
Share to Inactivation, Metabolic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoflavones

Share to Metabolic Syndrome

Share to Metabolomics

Share to Phenotype

Share to Risk Factors

Source

Identifiers

PMID: 27364093
DOI: 10.1002/mnfr.201600132

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors.PMID 27364093Read ↗

Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.Semantic proximity Read ↗

Cardiovascular disease risk factors in women with O-desmethylangolensin producing and non-producing gut microbial metabotypes: an observational study.Semantic proximity Read ↗

Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States.Semantic proximity Read ↗

Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China.Semantic proximity Read ↗

O-desmethylangolensin: the importance of equol's lesser known cousin to human health.Semantic proximity Read ↗

Phenotypic differences between equol-producing and non-equol-producing intestinal microbiota.Semantic proximity Read ↗

Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls.Semantic proximity Read ↗

A gnotobiotic mouse model with divergent equol-producing phenotype: potential for determining microbial-driven health impacts of soy isoflavone daidzeinSemantic proximity Read ↗

A Gnotobiotic Mouse Model with Divergent Equol-Producing Phenotypes: Potential for Determining Microbial-Driven Health Impacts of Soy Isoflavone Daidzein.Semantic proximity Read ↗

High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart.Semantic proximity Read ↗

Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women.Semantic proximity Read ↗

Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.